<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02882633</url>
  </required_header>
  <id_info>
    <org_study_id>822547Upenn</org_study_id>
    <nct_id>NCT02882633</nct_id>
  </id_info>
  <brief_title>Lumbar Plexus Block vs Fascia Iliaca Block After Hip Arthroscopy</brief_title>
  <official_title>Lumbar Plexus Block vs Fascia Iliaca Block After Hip Arthroscopy: A Non-inferiority Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare lumbar plexus block to fascia iliac block done in
      adult patients who have undergone hip arthroscopy surgery. Visual analogue scores, opioid
      consumption, and quality of recovery 48 hours post operatively will be used for comparison.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      If the patient is willing to participate and signs the consent, he/she will be randomized to
      one of the two treatment groups:

        1. Lumbar Plexus Block

        2. Fascia Iliaca Block

      The patient will undergo general anesthesia as by the attending anesthesiologist assigned to
      the case. No intraoperative restrictions will be required for this study. Once in the PACU,
      the patient will be assessed and if their pain score is â‰¥ 4 on the NRS, the patient will be
      randomized to a lumbar plexus block or fascia iliaca block.

      Patients will be monitored during block performance with standard ASA monitors. All patients
      will receive 2 L of oxygen via a nasal cannula. Sedatives will be titrated to effect.
      Midazolam 1-2 mg, and fentanyl 50-100 mcg will be used for sedation.

      The fascia iliaca block will be performed in a standard fashion as described2. The patient
      will be placed in a supine position. The ipsilateral groin will be prepped and cleaned with
      chlorhexidine. An ultrasound machine with a linear transducer covered with a sterile tegaderm
      will be utilized. The transducer is placed inferior to the inguinal ligament until the
      femoral artery is located. The probe is then moved laterally until the Sartorius muscle is
      seen. A skin wheal with 3ml of 1% lidocaine is made and a 2-inch blunt tip needle is inserted
      in plane. The needle is seen to pierce the fascia iliaca and 1-2 ml of 0.25% Preservative
      Free bupivacaine with 1:200,000 epinephrine is injected to confirm correct needle placement
      between the fascia iliaca and iliopsoas muscle. An injection will be deemed adequate if local
      anesthetic is seen to separate these two layers in a medial to lateral direction. A total of
      30ml of the above solution will be injected.

      The lumbar plexus block will be performed with the patient placed in a lateral position with
      the operative side facing up. An ultrasound machine with a curved transducer covered with a
      sterile tegaderm will be utilized. The ipsilateral hip and knee will be flexed to 90 degrees.
      The anatomy for the LP block will be localized using a modified transverse scan of the lumbar
      paravertebral area (PMTS). This technique is well described by Karmarkar et al.7 The target
      vertebral level will be identified by locating the lumbosacral junction (the gap of L5-S1)
      using a paramedian sagittal scan and then counting cranially to locate both the lamina and
      the transverse process of L3-L5. The transducer is then placed 4 cm lateral to the midline at
      the L3-4 level and directed medially to insonate the intervertebral foramen through the
      lumbar intervertebral space. A skin wheal is made at this site with 1% lidocaine. and a 4
      inch blunt tip needle is introduced 4 cm lateral to the midline and just medial of the
      transducer after connecting it to a nerve stimulator set at 1.00 mA. The needle is slowly
      advanced under ultrasound guidance until engaged in the psoas compartment and a quadriceps
      twitch is elicited. The nerve stimulator is turned down until the twitch is abolished at
      0.3mA or less. 1-2cmlof 0.25% Preservative free Bupivacaine with 1:200,000 epinephrine is
      injected slowly after negative aspiration. A total of 30ml will be injected. Spread will be
      confirmed with ultrasound.

      All patients will receive prophylaxis for postoperative nausea and vomiting (PONV) during
      surgery. The protocol for prophylaxis against PONV includes administration of 4 mg of
      dexamethasone after induction of anesthesia and 4 mg of ondansetron 20 minutes before
      recovery from anesthesia. Dexamethasone is withheld if the patient has poorly controlled
      diabetes mellitus (DM). Uncontrolled DM will be defined as random blood glucose above 250
      mg/dl.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Actual">May 2018</completion_date>
  <primary_completion_date type="Actual">May 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain Score Change</measure>
    <time_frame>Change from baseline through 15 minutes</time_frame>
    <description>Change in pain scores, as measured by the Visual Analog Scale (0-10). 10 is worst imaginable pain and 0 means no pain at all.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Amount of Opiate Consumption</measure>
    <time_frame>While in PACU. An average length of stay for Lumbar Plexus Block group was 165.04 min and 139.72 min for Fascia Iliaca Block group.</time_frame>
    <description>Participants need for pain relief as measured by opiate consumption</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of Recovery</measure>
    <time_frame>Change from baseline through 24 hours</time_frame>
    <description>Score of QoR survey to determine recovery status. 0-18 where 0 is the worst and 18 is the best feeling.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Hip Arthroscopy</condition>
  <condition>Nerve Block</condition>
  <arm_group>
    <arm_group_label>Lumbar Plexus Block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects will receive single shot local anesthetic, 30 ml bolus of bupivacaine, given preoperatively to help with postoperative pain</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fascia Iliac Block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects will receive single shot local anesthetic, 30 ml bolus of bupivacaine, given preoperatively to help with postoperative pain</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>30ml bolus of bupivacaine</intervention_name>
    <description>Local anesthetic</description>
    <arm_group_label>Fascia Iliac Block</arm_group_label>
    <arm_group_label>Lumbar Plexus Block</arm_group_label>
    <other_name>Marcaine</other_name>
    <other_name>Sensorcaine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients18 years and older scheduled for hip arthroscopy surgery

          -  American Society of Anesthesiologists (ASA) physical status I -III

          -  Mentally competent and able to give consent for enrollment in the study

        Exclusion Criteria:

          -  Chronic opioid use (use of any opioid daily or on most days of the week for more than
             3 months)

          -  Diagnosed peripheral neuropathy in the surgical lower extremity

          -  Allergy to study medications

          -  BMI &gt;42
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ignacio Badiola, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Univeristy of Pennsylvania</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>August 16, 2016</study_first_submitted>
  <study_first_submitted_qc>August 24, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 30, 2016</study_first_posted>
  <results_first_submitted>April 15, 2019</results_first_submitted>
  <results_first_submitted_qc>May 23, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">June 11, 2019</results_first_posted>
  <last_update_submitted>May 23, 2019</last_update_submitted>
  <last_update_submitted_qc>May 23, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 11, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>lumbar plexus block</keyword>
  <keyword>fascia iliac block</keyword>
  <keyword>quality of recovery score</keyword>
  <keyword>pain score</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>June 1, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/33/NCT02882633/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Lumbar Plexus Block</title>
          <description>Subjects will receive single shot local anesthetic, 30 ml bolus of bupivacaine, given preoperatively to help with postoperative pain
30ml bolus of bupivacaine: Local anesthetic</description>
        </group>
        <group group_id="P2">
          <title>Fascia Iliac Block</title>
          <description>Subjects will receive single shot local anesthetic, 30 ml bolus of bupivacaine, given preoperatively to help with postoperative pain
30ml bolus of bupivacaine: Local anesthetic</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
                <participants group_id="P2" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
                <participants group_id="P2" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Lumbar Plexus Block</title>
          <description>Subjects will receive single shot local anesthetic, 30 ml bolus of bupivacaine, given preoperatively to help with postoperative pain
30ml bolus of bupivacaine: Local anesthetic</description>
        </group>
        <group group_id="B2">
          <title>Fascia Iliaca Block</title>
          <description>Subjects will receive single shot local anesthetic, 30 ml bolus of bupivacaine, given preoperatively to help with postoperative pain
30ml bolus of bupivacaine: Local anesthetic</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="23"/>
            <count group_id="B2" value="25"/>
            <count group_id="B3" value="48"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="23"/>
                    <count group_id="B2" value="25"/>
                    <count group_id="B3" value="48"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38.83" spread="11.55"/>
                    <measurement group_id="B2" value="39.8" spread="11.40"/>
                    <measurement group_id="B3" value="39.34" spread="11.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="23"/>
                    <count group_id="B2" value="25"/>
                    <count group_id="B3" value="48"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="32"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="23"/>
                    <count group_id="B2" value="25"/>
                    <count group_id="B3" value="48"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29.89" spread="6.59"/>
                    <measurement group_id="B2" value="26.80" spread="4.52"/>
                    <measurement group_id="B3" value="28.28" spread="5.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Femoral/Acetabular osteoplasty</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="23"/>
                    <count group_id="B2" value="25"/>
                    <count group_id="B3" value="48"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Peri-trochanteric space surgery</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="23"/>
                    <count group_id="B2" value="25"/>
                    <count group_id="B3" value="48"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Pain Score Change</title>
        <description>Change in pain scores, as measured by the Visual Analog Scale (0-10). 10 is worst imaginable pain and 0 means no pain at all.</description>
        <time_frame>Change from baseline through 15 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lumbar Plexus Block</title>
            <description>Subjects will receive single shot local anesthetic, 30 ml bolus of bupivacaine, given preoperatively to help with postoperative pain
30ml bolus of bupivacaine: Local anesthetic</description>
          </group>
          <group group_id="O2">
            <title>Fascia Iliac Block</title>
            <description>Subjects will receive single shot local anesthetic, 30 ml bolus of bupivacaine, given preoperatively to help with postoperative pain
30ml bolus of bupivacaine: Local anesthetic</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Score Change</title>
          <description>Change in pain scores, as measured by the Visual Analog Scale (0-10). 10 is worst imaginable pain and 0 means no pain at all.</description>
          <units>change in score on a scale</units>
          <param>Mean</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" lower_limit="1" upper_limit="3"/>
                    <measurement group_id="O2" value="1.72" lower_limit="0" upper_limit="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Amount of Opiate Consumption</title>
        <description>Participants need for pain relief as measured by opiate consumption</description>
        <time_frame>While in PACU. An average length of stay for Lumbar Plexus Block group was 165.04 min and 139.72 min for Fascia Iliaca Block group.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lumbar Plexus Block</title>
            <description>Subjects will receive single shot local anesthetic, 30 ml bolus of bupivacaine, given preoperatively to help with postoperative pain
30ml bolus of bupivacaine: Local anesthetic</description>
          </group>
          <group group_id="O2">
            <title>Fascia Iliac Block</title>
            <description>Subjects will receive single shot local anesthetic, 30 ml bolus of bupivacaine, given preoperatively to help with postoperative pain
30ml bolus of bupivacaine: Local anesthetic</description>
          </group>
        </group_list>
        <measure>
          <title>Amount of Opiate Consumption</title>
          <description>Participants need for pain relief as measured by opiate consumption</description>
          <units>mg</units>
          <param>Mean</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.98" lower_limit="5.81" upper_limit="22.5"/>
                    <measurement group_id="O2" value="20.80" lower_limit="5.62" upper_limit="33.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Quality of Recovery</title>
        <description>Score of QoR survey to determine recovery status. 0-18 where 0 is the worst and 18 is the best feeling.</description>
        <time_frame>Change from baseline through 24 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lumbar Plexus Block</title>
            <description>Subjects will receive single shot local anesthetic, 30 ml bolus of bupivacaine, given preoperatively to help with postoperative pain
30ml bolus of bupivacaine: Local anesthetic</description>
          </group>
          <group group_id="O2">
            <title>Fascia Iliac Block</title>
            <description>Subjects will receive single shot local anesthetic, 30 ml bolus of bupivacaine, given preoperatively to help with postoperative pain
30ml bolus of bupivacaine: Local anesthetic</description>
          </group>
        </group_list>
        <measure>
          <title>Quality of Recovery</title>
          <description>Score of QoR survey to determine recovery status. 0-18 where 0 is the worst and 18 is the best feeling.</description>
          <units>Score on a scale</units>
          <param>Mean</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.52" lower_limit="14" upper_limit="17"/>
                    <measurement group_id="O2" value="15.91" lower_limit="11" upper_limit="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse Effects data collected day of procedure and following 48 hours</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Lumbar Plexus Block</title>
          <description>Subjects will receive single shot local anesthetic, 30 ml bolus of bupivacaine, given preoperatively to help with postoperative pain
30ml bolus of bupivacaine: Local anesthetic</description>
        </group>
        <group group_id="E2">
          <title>Fascia Iliac Block</title>
          <description>Subjects will receive single shot local anesthetic, 30 ml bolus of bupivacaine, given preoperatively to help with postoperative pain
30ml bolus of bupivacaine: Local anesthetic</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Epidural Spread</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Epidural Spread</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Ignacio Badiola</name_or_title>
      <organization>University of Pennsylvania</organization>
      <phone>215-893-7251</phone>
      <email>Ignacio.Badiola@uphs.upenn.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

